Barr Pharmaceuticals, Inc. is a global specialty pharmaceutical company that operates in more than thirty countries worldwide and is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients. A holding company, Barr operates through its principal subsidiaries: Barr Laboratories, Inc., Duramed Pharmaceuticals, Inc. and PLIVA d.d. and its subsidiaries. The Company markets more than one hundred and twenty generic and twenty five proprietary products in the U.S. and more than five hundred fifty products globally outside of the U.S.